Company news
Blue Water Ventures International, Inc. (OTC:BWVI) news
Blue Water Ventures International, Inc. news releases on 6ix. Latest, May 16, 2024: Historical Regulatory Filing Deficiences Continue to Stifle Psycheceutical…
Press releases & updates
Historical Regulatory Filing Deficiences Continue to Stifle Psycheceutical Biosciences
May 15, 2024
Psycheceutical Bioscience Strategically Pivots Into the Brain-Computer Interface (BCI) Space
January 16, 2024
Dr. Neilank Jha Appointed as Executive Chairman and Chief Executive Officer of Psycheceutical Bioscience Inc.
December 11, 2023
Psycheceutical Bioscience Launches Wefunder Crowdfunding Campaign for Safer Psychedelic Dosing
October 31, 2023
Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose Escalation in Phase I Trial of NeuroDirect Ketamine for PTSD
August 9, 2023
Psycheceutical Bioscience Announces Completion of PCAOB Audit and Future Corporation Action Strategy
July 31, 2023
First Patient Dosed in Psycheceutical's Phase I Study Exploring Topical Administration of Ketamine to Treat PTSD
July 12, 2023
Psycheceutical Secures Funding for Clinical Trials of NeuroDirect™ Ketamine Topical to Treat PTSD
May 31, 2023
The Next Generation Of Mental Health Treatment: Psycheceutical Bioscience Inc.’s (OTCPK:BWVI) Novel Topical Ketamine Delivery
April 17, 2023
Psycheceutical Bioscience, Inc. Named a 2023 Top 10 Biotech Startup by Life Sciences Review
April 12, 2023
Psycheceutical Hosts MAPS Founder and Psychedelic Industry Leader Rick Doblin at Its Drug Development Lab
March 28, 2023
Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD
March 20, 2023
Psycheceutical to Conduct the First Ever Phase I and II Clinical Trials of a Novel Ketamine Topical Cream to Treat PTSD
February 15, 2023
Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Topical Ketamine Drug to Treat PTSD
February 2, 2023
Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD
January 26, 2023
Psycheceutical Announces Julian Bailes, M.D. as Board Member and Chief Medical Officer
January 10, 2023
Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director
November 29, 2022
Psycheceutical Bioscience, Inc. Announces Medical Advisory Board
October 18, 2022
Psycheceutical Bioscience, Inc.'s Zappy Zapolin Added to The Benzinga Psychedelics Advisory Council
October 4, 2022
Watch the Psycheceutical Bioscience, Inc. Presentation at the September 15, 2022 Life Sciences Investor Forum
September 16, 2022
Life Sciences Virtual Investor Conference: Presentations Now Available for On-Demand Viewing
September 16, 2022
Psycheceutical Bioscience, Inc.'s CEO to Present at the Life Sciences Investor Forum on September 15
September 13, 2022
Life Sciences Virtual Investor Conference Agenda Announced for September 15th
September 12, 2022
Psycheceutical Bioscience, Inc. Enters into Exclusive Option to Acquire Vici Health Sciences
August 16, 2022
Psycheceutical Brings on Original Shark from 'Shark Tank,' Kevin Harrington, as Investor and Strategic Advisor
May 10, 2022
Psycheceutical’s Chief Visionary Officer Zappy Zapolin Speaking at Legacy Investment Summit Alongside Entrepreneur Peter Diamandis
March 27, 2022
Psycheceutical Completes Acquisition by Blue Water Ventures International
January 20, 2022
Blue Water Ventures International, Inc. Signs Non-Binding Letter of Intent to Acquire Psycheceutical, Inc.
November 3, 2021
Blue Water Ventures International and Partners Endurance Exploration Group Share Update on the Current 2021 Recovery Season of Steamboat Pulaski
August 25, 2021
New Sonar Survey Discovers Large Unsalvaged Sections of SB Pulaski, 1838
June 23, 2021
Blue Water Ventures International Signs Extension on Pulaski Recovery
March 17, 2021
Blue Water Ventures International 2020 Season is in Motion
July 28, 2020
Blue Water Ventures International Announces 2020 Recovery Season
April 8, 2020
Blue Water Ventures International and Endurance Exploration Group Announce First Day Success on Steamboat North Carolina
October 2, 2019
BWVI and EXPL Continue to Work Through 2019 Season
July 10, 2019
Blue Water Ventures International, Inc. Has Begun Site Survey Work Off the Coast of North and South Carolina
May 15, 2019
Blue Water Ventures International, Inc. and Project Partner Endurance Exploration Group, Inc. Announce Preparations for 2019 Operations
March 29, 2019
A Portion of Pulaski Shipwreck Coin Collection Has Sold
February 13, 2019
BWVI and Its Branding Partner SponsorsOne Announce Their New Campagn for 2019 Featuring Shipwreck Jewelry By Bradford James and Benefiting The Thirst Project
January 9, 2019
Blue Water Launches Long Awaited Treasure Line with Partners SponsorsOne and Bradford James
January 2, 2019
Blue Water Ventures International Joins SponsorsOne’s Brand Building and E-Commerce Platform
October 30, 2018
Operations are Being Expanded to Include the Wreck Believed to be the SS North Carolina
October 24, 2018
The Pulaski Salvage Project Has Been Extended for Two Years
October 16, 2018
Ownership of All Recovered Pulaski Artifacts Has Been Granted By US Federal District Court
October 4, 2018
Update on Pulaski Recovery Project, Coins and Artifacts
September 26, 2018
Update on Successful Recovery Efforts at SB Pulaski Wreck Site
July 11, 2018
Steamship Pulaski Recovery Efforts Increase Summer of 2018
June 6, 2018
Identity of the Shipwreck Steamboat Pulaski Confirmed, More Coins and Artifacts Recovered
May 9, 2018
Blue Water Ventures International and Endurance Exploration Extend Their Project Recovery Agreement
April 25, 2018
NCS and NGC Selected to Conserve and Grade SS Pulaski Coins
March 27, 2018